• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • tislelizumab
    1 Drug classified under this active ingredient


    All the Active Ingredient Drugs

    TEVIMBRA
    BeiGene Pharmaceuticals Israel Ltd.
    RX
    not in the basket chart
    TEVIMBRA

    Anti PD-1 Monoclonal Antibody. tislelizumab 100 mg.
    Vial. Conc. for sol. for infus. 100 mg/10 ml (1 or 2 Vials)
    Dose: 200 mg IV once /3 weeks.
    Treat until dis. progress. or unacceptable tox.
    Oesophageal sq. cell carcinoma (OSCC)
    As monother. for adlts. with unresectable, locally adv. or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemother.

    C/I:
      Hypersens

    CLOSE